Formidable Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Formidable Asset Management’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-67	Closed	-$222K	–	251
2019 Q1	$222K	Buy	+67	New	+$14.8K	0.09%	158
2016 Q2	–	Sell	-333	Closed	-$22K	–	213
2016 Q1	$22K	Hold	333	–	–	0.02%	266
2015 Q4	$14K	Hold	333	–	–	0.01%	342
2015 Q3	$15K	Buy	+333	New	+$22.2K	0.01%	348

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Formidable Asset Management's CRBP Position: Q2 2019 in Review

Formidable Asset Management sold out of Corbus Pharmaceuticals (CRBP) in Q2 2019, closing a stake of 67 shares — an estimated $222K sold.

Formidable Asset Management first reported a position in CRBP in Q3 2015 and held it in 4 quarters. The position peaked at $222K in Q1 2019. 103 funds tracked by Wall St. Rank hold CRBP as of Q2 2019.

Formidable Asset Management reported no remaining Corbus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Formidable Asset Management sold 67 Corbus Pharmaceuticals shares in Q2 2019, an estimated $222K.
Formidable Asset Management first reported a position in Corbus Pharmaceuticals in Q3 2015 and held it in 4 quarters.
Formidable Asset Management's Corbus Pharmaceuticals position peaked at $222K in Q1 2019.
103 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2019.

Based on Formidable Asset Management's 13F filing for Q2 2019, filed 15 Oct 2019.